Skip to content

The effect of Hyoscine butyl bromide on the duration of the first stage of labour in nulliparous women: A randomised controlled trial in Wuse District Hospital, Abuja.

The effect of Hyoscine butyl bromide on the duration of the first stage of labour in nulliparous women: A randomised controlled trial in Wuse District Hospital, Abuja.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
PACTR
Registry ID
PACTR202402717378543
Enrollment
136
Registered
2024-02-21
Start date
2022-10-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

1ML OF STERILE WATER

Sponsors

DR. YIBALA EDIMEK
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1 Inclusion Criteria i. Nulliparous Parturients in active phase of labour (cervical dilatation of 4cm) ii. Patients who gave informed consent to the study. iii. Term Gestation (37 completed - 42 weeks) iv. Singleton pregnancy in cephalic presentation v. Absence of contraindication to vaginal delivery vi. Spontaneous labour

Exclusion criteria

Exclusion criteria: 2 Exclusion Criteria i. Patients with uterine scar ii. Patients with fetal malpresentation iii. Patients with Chronic hypertension, Pre-gestational Diabetes, Gestational diabetes, Pregnancy induced hypertension or Preeclampsia iv. Multiple gestation v. Multiparous patients vi. Hypersensitivity to Hyoscine vii. Contraindications to vaginal delivery

Design outcomes

Primary

MeasureTime frame
The primary outcome measure was the duration of the first stage of labour.

Secondary

MeasureTime frame
The secondary outcome measures were the duration of the second and third stages of labour, maternal drug side effects, Apgar scores of the neonates and need for neonatal admission.

Countries

Nigeria

Contacts

Public ContactJOYCE;JONATHAN EZEUGO;EDIMEK

CONSULTANT FCTA HOSPITALS;MEDICAL DOCTOR

joyce_chychy@yahoo.com;jonathan.edimek@yahoo.com+2348039484764;+2348037268189

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026